115 related articles for article (PubMed ID: 15771458)
1. Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.
Janssens F; Leenaerts J; Diels G; De Boeck B; Megens A; Langlois X; van Rossem K; Beetens J; Borgers M
J Med Chem; 2005 Mar; 48(6):2154-66. PubMed ID: 15771458
[TBL] [Abstract][Full Text] [Related]
2. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
[TBL] [Abstract][Full Text] [Related]
5. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological investigation of novel 1-substituted-4-(4-substituted phenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as a new class of H1-antihistamine agents.
Alagarsamy V; Giridhar R; Yadav MR
J Pharm Pharmacol; 2006 Sep; 58(9):1249-55. PubMed ID: 16945184
[TBL] [Abstract][Full Text] [Related]
7. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
Van Wauwe J; Awouters F; Neimegeers CJ; Janssens F; Van Nueten JM; Janssen PA
Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T
Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
Tsukamoto I; Koshio H; Kuramochi T; Saitoh C; Yanai-Inamura H; Kitada-Nozawa C; Yamamoto E; Yatsu T; Shimada Y; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2009 Apr; 17(8):3130-41. PubMed ID: 19321349
[TBL] [Abstract][Full Text] [Related]
11. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T
J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
13. A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference.
Sawada Y; Kayakiri H; Abe Y; Imai K; Mizutani T; Inamura N; Asano M; Aramori I; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 2004 Mar; 47(7):1617-30. PubMed ID: 15027853
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
[TBL] [Abstract][Full Text] [Related]
16. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
17. 1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand.
Quaglia W; Giannella M; Piergentili A; Pigini M; Brasili L; Di Toro R; Rossetti L; Spampinato S; Melchiorre C
J Med Chem; 1998 May; 41(10):1557-60. PubMed ID: 9572880
[No Abstract] [Full Text] [Related]
18. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
Meerpoel L; Backx LJ; Van der Veken LJ; Heeres J; Corens D; De Groot A; Odds FC; Van Gerven F; Woestenborghs FA; Van Breda A; Oris M; van Dorsselaer P; Willemsens GH; Vermuyten KJ; Marichal PJ; Vanden Bossche HF; Ausma J; Borgers M
J Med Chem; 2005 Mar; 48(6):2184-93. PubMed ID: 15771461
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists.
Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Vilella D; Aparici M; Prieto J; Warrellow G; Beleta J; Ryder H
Bioorg Med Chem Lett; 2005 Feb; 15(4):1165-7. PubMed ID: 15686934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
